Literature DB >> 29862153

Current status of malignant mesothelioma with liver involvement in China: A brief report and review of the literature.

Di Zhou1, Zhiwei Quan1, Jiandong Wang1.   

Abstract

Primary and secondary intrahepatic malignant mesothelioma (PIHMM & SIHMM) caused by Peritoneal mesothelioma (PM) are extremely rare tumors and their clinicopathological characteristics remain unclear. The current study presented a case of a 63-year-old female with PIHMM and a literature review of Chinese case reports of SIHMM and PIHMM was performed. The patient received curative left hemihepatectomy because of a 5.5 × 5.0 × 4.0 cm mass occupying the II, III and the lateral portion of the IV segments and meanwhile tightly infiltrating the diaphragm (yellow arrow) was also observed. The pathological diagnosis was epithelial type PIHMM. Immunohistochemistry revealed that the tumor was positive for Calretinin, CK5/6, WT-1 and D2-40(N). The literature review included 11 studies and 6 case reports with a total of 293 PM patients accompanied with 31 SIHMM cases and then 3 case reports of PIHMM. SIHMM and PIHMM are extremely rare, easy to misdiagnose malignant tumors. Immunohistochemistry should be performed strictly in accordance with guidelines, which is crucial for pathological diagnosis. Comprehensive treatment of surgery combined with chemotherapy are mainstream methods for SIHMM and PIHMM. Also, exact survival data should be carefully explored so that objective evaluation of the efficacy of the treatment could be achieved.

Entities:  

Keywords:  China; Malignant mesothelioma; liver involvement

Year:  2018        PMID: 29862153      PMCID: PMC5982618          DOI: 10.5582/irdr.2018.01052

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  22 in total

1.  [Diagnosis and treatment of 41 patients with malignant peritoneal mesothelioma].

Authors:  Zhong-guo Zhang; Xi-shan Hao
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2004-10

2.  Malignant mesothelioma of the peritoneum invading the liver and mimicking metastatic carcinoma: a case report.

Authors:  Shigenori Nagata; Miki Tomoeda; Chiaki Kubo; Hidenori Yoshizawa; Michiko Yuki; Masanori Kitamura; Akemi Takenaka; Katsuyuki Nakanishi; Toshiya Yagi; Fumio Imamura; Yasuhiko Tomita
Journal:  Pathol Res Pract       Date:  2011-05-20       Impact factor: 3.250

Review 3.  Animal models of malignant mesothelioma.

Authors:  Agnes B Kane
Journal:  Inhal Toxicol       Date:  2006-11       Impact factor: 2.724

4.  Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.

Authors:  Aliya Noor Husain; Thomas V Colby; Nelson G Ordóñez; Timothy Craig Allen; Richard Luther Attanoos; Mary Beth Beasley; Kelly Jo Butnor; Lucian R Chirieac; Andrew M Churg; Sanja Dacic; Françoise Galateau-Sallé; Allen Gibbs; Allen M Gown; Thomas Krausz; Leslie Anne Litzky; Alberto Marchevsky; Andrew G Nicholson; Victor Louis Roggli; Anupama K Sharma; William D Travis; Ann E Walts; Mark R Wick
Journal:  Arch Pathol Lab Med       Date:  2017-07-07       Impact factor: 5.534

Review 5.  Breath analysis in asbestos-related disorders: a review of the literature and potential future applications.

Authors:  Eleanor A Chapman; Paul S Thomas; Deborah H Yates
Journal:  J Breath Res       Date:  2010-08-27       Impact factor: 3.262

6.  Primary malignant mesothelioma of the liver: MR imaging findings.

Authors:  Polytimi Leonardou; Richard C Semelka; Masayuki Kanematsu; Larissa Braga; John T Woosley
Journal:  Magn Reson Imaging       Date:  2003-11       Impact factor: 2.546

7.  Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.

Authors:  Piero Borasio; Alfredo Berruti; Andrea Billé; Paolo Lausi; Matteo Giaj Levra; Roberto Giardino; Francesco Ardissone
Journal:  Eur J Cardiothorac Surg       Date:  2008-02       Impact factor: 4.191

8.  Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.

Authors:  Marcello Deraco; Paolo Casali; M G Inglese; Dario Baratti; Elisabetta Pennacchioli; Rossella Bertulli; Shigeki Kusamura
Journal:  J Surg Oncol       Date:  2003-07       Impact factor: 3.454

9.  Multiple primary hepatic malignant mesotheliomas mimicking cystadenocarcinomas on enhanced CT and FDG PET/CT.

Authors:  Aisheng Dong; Hui Dong; Changjing Zuo
Journal:  Clin Nucl Med       Date:  2014-07       Impact factor: 7.794

10.  Peritoneal metastases of rare carcinomas treated with cytoreductive surgery and HIPEC - A single center case series.

Authors:  Andreas Brandl; Christina Barbara Zielinski; Wieland Raue; Johann Pratschke; Beate Rau
Journal:  Ann Med Surg (Lond)       Date:  2017-08-09
View more
  2 in total

Review 1.  Primary malignant mesothelioma of the diaphragm with liver invasion: A case report and review of literature.

Authors:  Wen-Jing Huang; Zhi-Han Li; Zhao Wang; Mai-Qing Yang; Hong-Tao Xu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

2.  Diagnostic value and clinical significance of ultrasound combined with CT in cystic renal cell carcinoma.

Authors:  Minghui Sun; Chao Wang; Fei Jiang; Xiuhong Fang; Bingcheng Guo
Journal:  Oncol Lett       Date:  2019-05-30       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.